Mayo Clinic is main the way in which with a brand new therapy for superior prostate most cancers, particularly for prostate-specific membrane antigen-positive metastatic castration-resistant prostate most cancers (PSMA-positive mCRPC).
This therapy includes a radiopharmaceutical often known as Pluvicto. It acts like a wise missile, focusing on and eliminating most cancers cells.
Mayo Clinic consultants supply this remedy for sufferers whose prostate most cancers has unfold and is resistant to plain remedies corresponding to hormonal remedies and chemotherapy.
Dr. Oliver Sartor, a Mayo Clinic medical oncologist centered on prostate most cancers, says Mayo Clinic is on the forefront of treating sufferers with this novel remedy, providing new choices and hope for sufferers with superior prostate most cancers. He explains what this implies.
____________________________________________
FOR THE PUBLIC: More well being and medical information on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
FOR THE MEDIA ONLY: To entry clear and NAT sound variations of this video on the Mayo Clinic News Network, register at https://newsnetwork.mayoclinic.org/request-account/
Mayo Clinic: https://mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: https://www.facebook.com/MayoClinic
Follow Mayo Clinic on Instagram https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, previously Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
